Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
-
Shares outstanding
-
11,300,576
-
Total 13F shares
-
5,992,894
-
Share change
-
-6,548,879
-
Total reported value
-
$742,538,774
-
Put/Call ratio
-
44%
-
Price per share
-
$123.76
-
Number of holders
-
184
-
Value change
-
-$882,858,217
-
Number of buys
-
64
-
Number of sells
-
130
Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q3 2019
As of 30 Sep 2019,
First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by
184 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,992,894 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, UBS Group AG, ROYAL BANK OF CANADA, AMERIPRISE FINANCIAL INC, Raymond James Financial Services Advisors, Inc., MILLENNIUM MANAGEMENT LLC, LPL Financial LLC, and RAYMOND JAMES & ASSOCIATES.
This page lists
184
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.